Key result
Higher BMI linked to ~19% lower all-cause mortality in non-dialysis CKD patients.
Why the study?
It is unclear if the inverse relationship between BMI and mortality observed in hemodialysis patients also exists in non-dialysis CKD patients.
Is body mass index inversely associated with all-cause mortality in non-dialysis CKD patients with suspected cardiac chest pain?
Cohort (n=211)
Is body mass index inversely associated with all-cause mortality in non-dialysis CKD patients with suspected cardiac chest pain?
Hazard Ratio: 0.81 (95% CI 0.71–0.9)
A BMI paradox exists in non-dialysis CKD patients with suspected cardiac chest pain, where higher BMI is independently associated with lower all-cause mortality.
Should not alter BMI targets in non-dialysis CKD with suspected cardiac chest pain; hypothesis-generating for obesity paradox, needs prospective validation.
Background Chronic kidney disease (CKD) is a silent clinical condition associated with adverse comorbidity and high cardiovascular disease (CVD) risk. An inverse relationship with body mass index (BMI) and mortality has been demonstrated in hemodialysis patients. However, it is unclear if this risk‐factor paradox is evident in non‐dialysis CKD patients. The aims of this study were to explore the relationship between, nutritional status, markers of inflammation, autonomic and cardiac function with BMI. Longitudinal follow‐up explored the relationship between BMI and all‐cause mortality. Methods 211‐consecutive CKD patients referred for dobutamine stress echocardiography to detect or exclude myocardial ischemia were recruited. BMI, albumin, C‐reactive protein (CRP) and haemoglobin (Hb) were recorded as markers of nutritional and inflammatory status. Left ventricular ejection fraction (LVEF) and heart rate variability (HRV) as an indicator of cardiac function was recorded. All subjects were followed prospectively until November 2014 and study end‐point was all‐cause mortality. Results BMI was inversely associated with CKD status. After covariate adjustment, this association remained. During a mean follow‐up period of 3.3±0.9 years there were 35 deaths (17%). BMI was inversely associated with all‐cause mortality (HR 0.81, 95% CI 0.71–0.9). Other important independent predictors of mortality were heart rate variability (HR 0.98, 95% CI 0.97–0.99), myocardial ischemia (HR 1.37, 95% CI 1.17–1.81), and albumin (HR 0.86, 95% CI 0.81–0.92). Conclusions The presence of a BMI paradox exists in non‐dialysis CKD patients. This risk‐factor paradox was an independent predictor of all‐cause mortality and may have significant clinical implications relevant to screening, assessment and treatment and requires further study.
No takes yet. Share an insight, caveat, or question.
O’Driscoll et al. (2017) conducted a cohort in chronic kidney disease with suspected cardiac chest pain (n=211). Body mass index was evaluated on all-cause mortality (HR 0.81, 95% CI 0.71-0.9). In non-dialysis CKD patients, body mass index was inversely associated with all-cause mortality (HR 0.81; 95% CI 0.71-0.9).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: